Beta

Latest News Earnings Earning Calendar Analyst Rating Pricing

Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013

Business Wire•14/09/2026•12:00

0

Whiz Insights

No content available.

Terms & Conditions Privacy Policy Cookie Policy Disclaimer Contact

© 2026 Stockwhiz. All rights reserved.

Market information and AI summaries are provided for informational purposes only.